Alzheimer disease: open trials in Chile

10 open trials have a site in Chile. Registry data; only the trial team decides who can take part.

NCT07717411
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Trial Treatment · Phase 3 · Hoffmann-La Roche
Clinica MEDS, Santiago
Registry updated 2026-11-06
NCT06159673
ACP-204 in Adults With Alzheimer's Disease Psychosis
Trial Treatment · Phase 2/3 · ACADIA Pharmaceuticals Inc.
Psicomed Estudios Medicos, Antofagasta · CIC de la Universidad Catolica CICUC, Santiago · Especialidades Medicas L y S, Santiago · Biomedica Research Group, Santiago
Registry updated 2026-11-05
NCT06194799
ACP-204 in Adults With Alzheimer's Disease Psychosis Open Label Extension Study
Trial Treatment · Phase 3 · ACADIA Pharmaceuticals Inc.
Psicomed Estudios Medicos, Antofagasta · CIC de la Universidad Catolica CICUC, Santiago · Biomedica Research Group, Santiago · Especialidades Medicas L y S, Santiago
Registry updated 2026-11-04
NCT07011745
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Psicomed Estudios Médicos Cía Ltda, Antofagasta · Santiago · Pontificia Universidad Catolica de Chile, Santiago · Biomedica Research Group, Santiago · Viña del Mar · Clinica Alemana, Vitacura
Registry updated 2026-11-03
NCT06976216
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Antofagasta · Santiago · Especialidades Médicas LYS, Santiago · Santiago
Registry updated 2026-10-27
NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Trial Treatment · Phase 3 · Hoffmann-La Roche
Hospital Clínico Universidad de Chile, Santiago · Icegclinic, Santiago · Centro de Medicina de Precisión, Santiago · Clinica Las Condes, Santiago · Clinica MEDS, Santiago · Biomedica Research Group, Santiago · Centro de Investigación Clínica UC-CICUC, Santiago · Clinical Research Valdivia, Valdivia
Registry updated 2026-10-19
NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Psicomed Estudios Medicos, Antofagasta · Especialidades Medicas L Y S, Las Condes · Biomedica Research Group, Providencia
Registry updated 2026-10-16
NCT06126224
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)
Trial Treatment · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Psicomed Estudios Medicos, Antofagasta · Las Condes · Las Condes · Biomedica Research Group, Providencia
Registry updated 2026-10-16
NCT06937229
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
Trial Treatment · Phase 3 · Bristol-Myers Squibb
Antofagasta · Santiago · Santiago · Viña del Mar · Vitacura
Registry updated 2026-10-16
NCT06887192
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Trial Treatment · Phase 2 · MapLight Therapeutics
Antofagasta · Santiago
Registry updated 2026-09-30

All Alzheimer disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error